SequelSEC

SHOULDER INNOVATIONS, INC. SI

Surgical & Medical Instruments & Apparatus · CIK 0001699350 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$60.06M
Fiscal year ended 2026-06-30
Operating income
-$35.15M
Fiscal year ended 2026-06-30
Free cash flow
-$47.08M
Fiscal year ended 2026-06-30

SHOULDER INNOVATIONS, INC. (SI) reported revenue of $60.06M and net income of -$35.03M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from SHOULDER INNOVATIONS, INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

SHOULDER INNOVATIONS, INC. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$60.06M
Cost of revenue$13.61M
Gross profit$46.44M
Operating income-$35.15M
Net income-$35.03M
Research & development$11.89M
Weighted-average diluted sharesUnavailable
Pretax income-$35.03M
Income tax expense$0
Diluted EPSUnavailable
Selling, general & administrative$69.71M
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

SHOULDER INNOVATIONS, INC. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$24.46M
Total assets$152.01M
Current assets$137.41M
Total liabilities$27.68M
Current liabilities$12.83M
Total equity incl. NCI$124.33M
Temporary (mezzanine) equity$0
Inventory$22.92M
Accounts receivable$10.87M
GoodwillUnavailable
Long-term debt$14.81M
Accounts payable$5.93M

Cash flow

SHOULDER INNOVATIONS, INC. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$37.09M
Capital expenditures$9.99M
Investing cash flow-$72.40M
Financing cash flow$106.89M
Net change in cashUnavailable
Stock-based compensation$2.49M
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortizationUnavailable

Derived

SHOULDER INNOVATIONS, INC. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow-$47.08M
Gross margin77.3%
Operating margin-58.5%
FCF margin-78.4%
SBC / revenue4.1%
Current ratio10.71x
Revenue YoY growth60.9%
Net margin-58.3%
R&D / revenue19.8%
CapEx / revenue16.6%
Long-term debt / equity0.12x
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open SI in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-06View SEC filing
10-Q · Filed 2026-05-13View SEC filing
10-K · Filed 2026-03-10View SEC filing
10-Q · Filed 2025-11-12View SEC filing
10-Q · Filed 2025-09-09View SEC filing

Companies in the same industry

ADGM AEMD ALUR AMIX ANGO ANIK AORT APYX ARAY ATEC ATRC AURX

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.